BiotechTube

Human Acellular Vessel (HAV)

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Peripheral Artery Disease

Conditions

Peripheral Artery Disease

Trial Timeline

Dec 20, 2016 → Dec 1, 2023

NCT ID
NCT02887859

About Human Acellular Vessel (HAV)

Human Acellular Vessel (HAV) is a phase 2 stage product being developed by Humacyte for Peripheral Artery Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT02887859. Target conditions include Peripheral Artery Disease.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (4)

NCT IDPhaseStatus
NCT03005418Phase 2/3Active
NCT03183245Phase 3Completed
NCT02887859Phase 2Completed
NCT02644941Phase 3Completed

Competing Products

20 competing products in Peripheral Artery Disease

See all competitors
ProductCompanyStageHype Score
SON-080Sonnet BioTherapeuticsPhase 1/2
36
LY3857210 + PlaceboEli LillyPhase 2
52
Pregabalin 150mg + Alpha-lipoic acid 480mg + Pregabalin 150mg + Alpha-Lipoic Acid 480mgYuhanApproved
85
YHD1119 + LyricaYuhanPhase 1
33
Anplag Tab. 100mg bid + Anplag Tab. 100mg tidYuhanApproved
85
YHD1119 + LyricaYuhanPhase 1
33
YHD1119 + LyricaYuhanPhase 3
77
YHD1119 300mg + YHD1119 300mgYuhanPhase 1
33
DS-5565 tablet + pregabalin capsule + Placebo tablet + placebo capsuleDaiichi SankyoPhase 2
52
edoxaban + Clopidogrel + AspirinDaiichi SankyoPhase 2
52
DS-5565 + placeboDaiichi SankyoPhase 3
77
Mirogabalin + PlaceboDaiichi SankyoPhase 3
77
DS-5565Daiichi SankyoPhase 3
77
Valemetostat TosylateDaiichi SankyoPhase 2
52
ASP3662 + pregabalin + ASP3662 placebo + pregabalin placeboAstellas PharmaPhase 2
52
QutenzaAstellas PharmaPre-clinical
23
QUTENZA + Lidocaine + TramadolAstellas PharmaApproved
85
Qutenza exposureAstellas PharmaPre-clinical
23
QUTENZAAstellas PharmaPhase 3
77
Qutenza + PregabalinAstellas PharmaApproved
85

Other Products from Humacyte

Acellular Tissue Engineered Vessel (ATEV)Phase 3
69
Human Acellular Vessel (HAV)Phase 3
69
Human Acellular Vessel (HAV)Phase 3
69
Human Acellular Vessel (HAV)Phase 2/3
57
HAVPhase 2
44